Session » 5T047: Plenary III (2727–2732)
-
Abstract Number: 2727
Mitochondrial Contribution to Juvenile Dermatomyositis Pathogenesis
-
Abstract Number: 2728
Efficacy and Safety of Upadacitinib in a Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2/3 Clinical Study of Patients with Active Ankylosing Spondylitis
-
Abstract Number: 2729
Ixekizumab in Non-Radiographic Axial Spondyloarthritis: Primary Results from a Phase 3 Trial
-
Abstract Number: 2730
Efficacy and Safety of Romosozumab vs Placebo Among Patients with Mild-to-Moderate Chronic Kidney Disease